Insider Selling: Intuitive Surgical (NASDAQ:ISRG) EVP Sells 105 Shares of Stock

March 12, 2026 by InsiderTrades.com

Key Points

Insider selling: EVP Myriam Curet sold 105 shares on March 10 at an average price of $493.95 for about $51,865 and has completed several other sales in recent weeks (e.g., 421 shares on Feb. 11), indicating ongoing insider profit-taking.
Strong Q4 but mixed market reaction: Intuitive reported Q4 revenue of $2.87 billion (+18.8% YoY) and EPS of $2.53 that beat estimates, yet the stock fell ~2.3% to $481.66 and currently trades at an elevated P/E of about 61.
Analyst and sentiment split: Wall Street maintains a largely bullish stance (consensus "Moderate Buy" with an average target ≈ $615.86), but concerns about 2026 procedure-growth deceleration and continued insider sales temper investor confidence.

Intuitive Surgical, Inc. (NASDAQ:ISRG - Get Free Report) EVP Myriam Curet sold 105 shares of Intuitive Surgical stock in a transaction dated Tuesday, March 10th. The shares were sold at an average price of $493.95, for a total value of $51,864.75. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.

5 Stocks Racing Ahead as AI Supercharges Robotics

Myriam Curet also recently made the following trade(s):

On Wednesday, February 11th, Myriam Curet sold 421 shares of Intuitive Surgical stock. The stock was sold at an average price of $494.96, for a total transaction of $208,378.16.
On Tuesday, February 10th, Myriam Curet sold 105 shares of Intuitive Surgical stock. The shares were sold at an average price of $494.65, for a total transaction of $51,938.25.
On Thursday, January 29th, Myriam Curet sold 126 shares of Intuitive Surgical stock. The shares were sold at an average price of $520.02, for a total transaction of $65,522.52.
On Tuesday, January 27th, Myriam Curet sold 230 shares of Intuitive Surgical stock. The shares were sold at an average price of $532.61, for a total transaction of $122,500.30.

Intuitive Surgical Trading Down 2.3%

ISRG traded down $11.21 during trading on Thursday, hitting $481.66. 363,897 shares of the company's stock were exchanged, compared to its average volume of 1,992,339. Intuitive Surgical, Inc. has a 1 year low of $425.00 and a 1 year high of $603.88. The stock has a 50 day moving average price of $516.79 and a 200 day moving average price of $512.60. The firm has a market cap of $171.05 billion, a P/E ratio of 61.01, a price-to-earnings-growth ratio of 3.75 and a beta of 1.66.

Beyond Biotech—3 Healthcare Stocks for Growth-Minded Investors

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last posted its earnings results on Thursday, January 22nd. The medical equipment provider reported $2.53 earnings per share for the quarter, beating the consensus estimate of $2.27 by $0.26. Intuitive Surgical had a net margin of 28.38% and a return on equity of 15.06%. The business had revenue of $2.87 billion for the quarter, compared to analyst estimates of $2.72 billion. During the same quarter in the previous year, the business posted $2.21 EPS. The business's quarterly revenue was up 18.8% on a year-over-year basis. Analysts forecast that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Intuitive Surgical

Hedge funds have recently bought and sold shares of the business. Riversedge Advisors LLC raised its position in shares of Intuitive Surgical by 1.9% during the 4th quarter. Riversedge Advisors LLC now owns 901 shares of the medical equipment provider's stock valued at $510,000 after acquiring an additional 17 shares in the last quarter. Fiduciary Financial Group LLC increased its stake in Intuitive Surgical by 2.1% during the fourth quarter. Fiduciary Financial Group LLC now owns 920 shares of the medical equipment provider's stock valued at $521,000 after purchasing an additional 19 shares during the last quarter. Prosperity Consulting Group LLC raised its holdings in shares of Intuitive Surgical by 0.5% during the third quarter. Prosperity Consulting Group LLC now owns 4,033 shares of the medical equipment provider's stock worth $1,804,000 after purchasing an additional 19 shares during the period. Rossmore Private Capital raised its holdings in shares of Intuitive Surgical by 2.0% during the third quarter. Rossmore Private Capital now owns 998 shares of the medical equipment provider's stock worth $446,000 after purchasing an additional 20 shares during the period. Finally, Activest Wealth Management lifted its position in shares of Intuitive Surgical by 21.7% in the 3rd quarter. Activest Wealth Management now owns 112 shares of the medical equipment provider's stock worth $50,000 after buying an additional 20 shares during the last quarter. Institutional investors and hedge funds own 83.64% of the company's stock.

Key Stories Impacting Intuitive Surgical

Intuitive Surgical Just Proved the Growth Engine Still Runs

Here are the key news stories impacting Intuitive Surgical this week:

Positive Sentiment: Citi upgraded ISRG to Buy and set a $590 price target, signaling near-term upside and helping lift sentiment toward the stock. Citigroup upgrades Intuitive Surgical (ISRG)
Positive Sentiment: Several bullish analyst pieces highlight ongoing momentum from the da Vinci 5 rollout, recurring revenue from instruments/software, and upside from Ion/SP platforms as drivers for continued procedure and revenue growth. Intuitive Surgical Poised for Growth in 2026 on da Vinci 5 Momentum
Positive Sentiment: Coverage noting ISRG’s strong Q4 results (19% revenue growth, EPS beat) and positive momentum is keeping investor interest elevated and helped the stock outperform peers on a strong trading day. Intuitive Surgical Inc. stock outperforms competitors on strong trading day
Neutral Sentiment: Bullish long-form analysis argues the company still has "massive growth ahead," reinforcing long-term case but not changing near-term valuation debates. Intuitive Surgical: The Robotic Surgery Leader Still Has Massive Growth Ahead
Neutral Sentiment: Valuation-focused pieces note that despite strong fundamentals and multi-year returns, near-term momentum has cooled and ISRG trades above its historical P/E—investors should weigh growth vs. elevated multiples. Assessing Intuitive Surgical (ISRG) Valuation As Shares Tread Water Despite Growth
Negative Sentiment: The Fool and other coverage flag management’s guidance for a deceleration in worldwide da Vinci procedure growth in 2026 — a potential drag on forward growth expectations. Intuitive Surgical Stock: Buy, Sell, or Hold?
Negative Sentiment: Company insiders (SVP and others) have been selling multiple lots recently, which can be read as profit-taking and may damp investor confidence despite the strong public narrative. SEC filing: Insider Sale Disclosures

Wall Street Analysts Forecast Growth

Several equities research analysts have recently weighed in on the company. The Goldman Sachs Group reaffirmed a "buy" rating and issued a $714.00 target price on shares of Intuitive Surgical in a research report on Friday, January 9th. Truist Financial boosted their price target on Intuitive Surgical from $620.00 to $650.00 and gave the stock a "buy" rating in a research report on Thursday, December 18th. Sanford C. Bernstein upped their price target on Intuitive Surgical from $740.00 to $750.00 and gave the stock an "outperform" rating in a report on Friday, January 23rd. HSBC increased their price objective on shares of Intuitive Surgical from $644.00 to $653.00 and gave the company a "buy" rating in a research report on Monday, January 26th. Finally, Argus reduced their target price on shares of Intuitive Surgical from $630.00 to $560.00 and set a "buy" rating on the stock in a research report on Wednesday, February 4th. Two research analysts have rated the stock with a Strong Buy rating, sixteen have issued a Buy rating, six have given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average price target of $615.86.

Get Our Latest Report on Intuitive Surgical

Intuitive Surgical Company Profile

(Get Free Report)

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon's hand movements into finer, scaled motions of small instruments inside the patient. Intuitive's business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.